BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 18559568)

  • 1. Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study.
    Franko A; Berti L; Guirguis A; Hennenlotter J; Wagner R; Scharpf MO; de Angelis MH; Wißmiller K; Lickert H; Stenzl A; Birkenfeld AL; Peter A; Häring HU; Lutz SZ; Heni M
    Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary and familial prostate cancer: biologic aggressiveness and recurrence.
    Potter SR; Partin AW
    Rev Urol; 2000; 2(1):35-6. PubMed ID: 16985733
    [No Abstract]   [Full Text] [Related]  

  • 3. Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.
    Izzo S; Naponelli V; Bettuzzi S
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32268584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.
    Anh NH; Long NP; Kim SJ; Min JE; Yoon SJ; Kim HM; Yang E; Hwang ES; Park JH; Hong SS; Kwon SW
    Metabolites; 2019 Sep; 9(10):. PubMed ID: 31546652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma.
    Zazzeroni F; Nicosia D; Tessitore A; Gallo R; Verzella D; Fischietti M; Vecchiotti D; Ventura L; Capece D; Gulino A; Alesse E
    Biomed Res Int; 2014; 2014():380398. PubMed ID: 25045667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
    Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of androgen receptor through androgen-converting enzymes is associated with biological aggressiveness in prostate cancer.
    Wako K; Kawasaki T; Yamana K; Suzuki K; Jiang S; Umezu H; Nishiyama T; Takahashi K; Hamakubo T; Kodama T; Naito M
    J Clin Pathol; 2008 Apr; 61(4):448-54. PubMed ID: 17720776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of genes related to androgen and estrogen metabolism in hereditary versus sporadic prostate cancer.
    Fromont G; Yacoub M; Valeri A; Mangin P; Vallancien G; Cancel-Tassin G; Cussenot O
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1505-9. PubMed ID: 18559568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.